21254 ⎘
Medicinal preparations containing active ingredients not provided for in groups -
Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
#602Dual-acting imidazole antihypertensive agents
#603GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS AND STATIN RESPONSE, METHODS OF DETECTION AND USES THEREOF
#604Methods of diagnosing and treating fibrosis
#605Dual-acting antihypertensive agents
#606Copper(I) Chloride Complex Of Nicotinic Acid And Pharmaceutical Compositions Containing The Same
#607Antagonists of IL-6 to raise albumin and/or lower CRP
#608IMAGING-BASED IDENTIFICATION OF A NEUROLOGICAL DISEASE OR A NEUROLOGICAL DISORDER
#609Compositions and methods for gene silencing
#610Modulators of pharmacokinetic properties of therapeutics
#611Benzene, pyridine, and pyridazine derivatives
#612Copper(1)Chloride Complex of Nicotinic Acid and Pharmaceutical Compositions Containing the Same
#613Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
#614Compositions and methods for prognosis of ovarian cancer
#615Dual-acting imidazole antihypertensive agents
#616Antibodies for the treatment of HIV
#617Anti-CD74 immunoconjugates and methods
#618Benzene, pyridine, and pyridazine derivatives
#619Compositions and methods for the treatment of cancer
#620Modified vitamin K-dependent polypeptides
#621Substituted aminopropionic derivatives as neprilysin inhibitors
#622Nucleoside phosphoramidates
#623Penetrating pharmaceutical foam
#624Methods for modulating Lyn kinase activity and treating related disorders
#625Crystalline forms of a biphenyl compound
#626Method for treating depression
#627Systems and methods for analyzing persistent homeostatic perturbations
#628Cyclosporin analogues for preventing or treating hepatitis C infection
#629Treating neoplasms with neurotoxin
#630Compositions and methods for treating hoof diseases
#631Inhibition of mitogen-activated protein kinases in cardiovascular disease
#632COMPOSITIONS AND METHODS FOR THE PREVENTION OF OXIDATIVE DEGRADATION OF PROTEINS
#633High-purity texaphyrin metal complexes
#634CRYSTALLINE FORMS OF A BIPHENYL COMPOUND
#635Penetrating pharmaceutical foam
#636Crystalline forms of a biphenyl compound
#637Methods of treating an inflammatory-related disease
#638Inhibitors of the unfolded protein response and methods for their use
#639Methylene urea derivatives
#640Modulators of pharmacokinetic properties of therapeutics
#641METHODS TO IDENTIFY INHIBITORS OF THE UNFOLDED PROTEIN RESPONSE
#642Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof
#643Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with PPI
#644OSTEOPOROSIS ASSOCIATED MARKERS AND METHODS OF USE THEREOF
#645Composition for treatment of sunburned skin
#646Pharmaceutical compositions comprising cyclosporin
#647Benzene, pyridine, and pyridazine derivatives
#648SYSTEMS AND METHODS FOR ANALYZING PERSISTENT HOMEOSTATIC PERTURBATIONS
#649Methods of treating fatty liver disease
#650Chlorthalidone combinations
#6512-{(R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1
#652Therapeutic protocols using hyaluronan
#653AGENT FOR CONTROL OF FUNCTION OF ANTIGEN-PRESENTING CELL
#654Dual-acting imidazole antihypertensive agents
#655ANTI-BACTERIAL AGENTS
#656Use of azapaullones for preventing and treating pancreatic autoimmune disorders
#657Bioadhesive Composition With Programmed Release
#658Compounds and methods for the treatment or prevention of flavivirus infections
#659Dual-acting antihypertensive agents
#660Generating vascular smooth muscle cells in vitro from ES cells
#661Osteoporosis associated markers and methods of use thereof
#662TREATMENT OF FIBROSIS
#663Modulators of pharmacokinetic properties of therapeutics
#664Benzene, Pyridine, and Pyridazine Derivatives
#665Recombinant A2-specific TNFα-specific antibodies
#666Modified vitamin K-dependent polypeptides
#667Modified vitamin K-dependent polypeptides
#668Methods of treating rheumatoid arthritis with anti-TNF antibodies
#669Crystalline forms of a biphenyl compound
#670Modified vitamin K-dependent polypeptides
#671Modified vitamin K-dependent polypeptides
#672Acellular bioabsorbable tissue regeneration matrices
#673Medicinal compositions containing Fc receptor γ chain activator
#674Modified vitamin K. dependent polypeptides
#675Chlorthalidone combinations
#676Crystalline forms of a biphenyl compound
#677Methods for modulating Lyn kinase activity and treating related disorders
#678High-purity texaphyrin metal complexes
#679Modified vitamin K-dependent polypeptides
#680Enhanced delivery of cells
#681Modified vitamin K-dependent polypeptides
#682Inhibition of nerve cell death by inhibiting degradation of shc3, atf6 or crebl1 by htra2 and method of ameliorating neurodegenerative diseases
#683Methods of treatment and diagnosis of patients with hepatitis c infection
#684Compositions containing micronized tanaproget prepared by wet granulation
#685Recombinant anti-TNF-α antibodies
#686Benzene, pyridine, and pyridazine derivatives
#687Methylene urea derivatives
#688Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof
#689Recombinant A2-specific TNFα-specific antibodies
#690Oral treatment compositions containing an anti-adhesion agent, antibacterial agent and incompatible compound
#691Purified amphiphilic peptide compositions and uses thereof
#692Polysaccharide-based polymer tissue adhesive for medical use
#693Inhibition of mitogen-activated protein kinases in cardiovascular disease
#694Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2
#695Methods of treating an inflammatory-related disease
#696Medicinal compositions containing fc receptor gamma-chain activator
#697Generating vascular smooth muscle cells in vitro from ES cells
#698Penetrating pharmaceutical foam
#699Compounds and methods for the treatment or prevention of infections
#700Process for treating glaucoma
#701Biocompatible polymeric compositions having microcrystalline and amorphous components and methods for their manufacture
#702Topical transdermal method for delivering nutrients through the skin for expedited wound healing and skin rejuvination